Business Wire

SKECHERS ÅBNER FØRSTE FLAGSHIP STORE I KØBENHAVN

9.4.2026 09:00:00 CEST | Business Wire | Pressemeddelelse

Del

Den 700 kvadratmeter store destination på Amagertorv byder på et dedikeret performanceområde sammen med virksomhedens innovative livsstils og komfortteknologier.

Som en del af udvidelsen af sit detailnetværk i Danmark bringer Skechers sine banebrydende performance og livsstils komfortteknologier til København med byens første Skechers flagship destination. Beliggende i hjertet af Amagertorv præsenterer den 700 kvadratmeter store butik brandets omfattende sortiment af prisvindende produkter, båret af førende atleter verden over, samt kendte innovationer som Skechers Hands Free Slip ins® og populære styles til alle livsstile.

Der er multimedier i denne pressemeddelelse. Se hele meddelelsen her: https://www.businesswire.com/news/home/20260409646752/da/

Skechers’ første flagship store i København åbner i hjertet af Amagertorv.

“Skechers har oplevet stærk vækst i Norden, særligt i Danmark. Vi har etableret en solid tilstedeværelse i regionen med 32 butikker i landet, og vores markante butik i København åbner på det helt rette tidspunkt og sted for at styrke vores position yderligere,” siger Michael Greenberg, præsident i Skechers. “At tilbyde fysiske universer, hvor kunder kan træde ind, udforske og opleve vores produkter på egen hånd, har transformeret alle dele af vores brand fra vores immersive World of Sports oplevelser til livsstils og performance destinationer. Denne altomfattende flagship store bliver en del af vores mest markante Skechers destinationer globalt og præsenterer nordiske forbrugere for de innovationer, den komfort, bekvemmelighed og værdi, der har gjort Skechers til et af Europas hurtigst voksende skobrand.”

“Vores enestående flagship butik og Amagertorvs centrale placering med høj trafik gør det til den perfekte ramme for at forbinde vores signatur Comfort That Performs med både lokale og besøgende fra hele verden,” tilføjer Peter Jørgensen, country manager for Skechers Nordics. “Amagertorv tilbyder en førsteklasses placering med maksimal synlighed blandt stærke internationale og danske brands, hvor vi kan præsentere hele vores univers og tilbyde en skooplevelse ud over det sædvanlige.”

Den moderne butik er en nyfortolkning af mid century design, oplyst af avancerede digitale LED skærme, grafiske elementer inspireret af København og endda en gigantisk Skechers Slip ins® sko. Her fremvises brandets populære livsstils kollektioner til alle aldre og aktiviteter fra athleisure, fashion, casual og work styles til damer og herrer til et dedikeret område med børneprodukter. Butikkens Skechers Performance område tilbyder et inspirerende univers af brandets innovationer, hvor atleter og entusiaster kan opleve et bredt udvalg inden for løb, fodbold, golf, court og padel, basketball og outdoor fodtøj.

Skechers kollektioner er udviklet med virksomhedens komfortinnovationer og banebrydende performance teknologier herunder Skechers Hyper Burst Pro Technology, Skechers Performance FitKnit® Technology, Skechers Hands Free Slip ins® Technology, Skechers Glide Step® Technology, Skechers Arch Fit® Technology, Skechers Max Cushioning® Technology og Skechers Air Cooled Memory Foam® Technology. Kunder vil også kunne opleve et unikt sortiment af Skechers tøj og accessories, som er nyt i Danmark.

Blandt de internationale eliteatleter, der konkurrerer i Skechers fodtøj, er nu også den danske fodboldspiller Matt O’Riley sammen med Anthony Elanga, Harry Kane, Mohammed Kudus, Romeo Lavia og Barış Alper Yılmaz. Derudover basketballstjerner som Joel Embiid, OG Anunoby, Julius Randle, Isaiah Hartenstein, Jackie Young, Rickea Jackson og Kiki Iriafen samt golfspillere som Brooke Henderson, Matt Fitzpatrick, Bernhard Langer og Max Greyserman.

Den nye butik på Amagertorv 11, 1160 København K, bliver en del af fire Skechers concept stores i København samt 27 øvrige lokationer i Danmark. Forbrugere kan også handle i cirka 5.300 Skechers butikker globalt, online på skechers.dk samt i stormagasiner og hos skoforhandlere verden over.

Om Sports Connection ApS og SKECHERS U.S.A., Inc.

Sports Connection ApS er et datterselskab af Skechers U.S.A., Inc., The Comfort Technology Company®, med base i det sydlige Californien. Skechers designer, udvikler og markedsfører et bredt udvalg af livsstils og performance fodtøj, tøj og accessories til damer, herrer og børn. Virksomhedens kollektioner er tilgængelige i 180 lande og territorier via stormagasiner og specialbutikker samt direkte til forbrugere via skechers.com og cirka 5.300 Skechers butikker. Som en Fortune 500® virksomhed driver Skechers sin internationale forretning gennem et netværk af egne datterselskaber, joint venture partnere og distributører. or mere information besøg about.skechers.com og følg os på Facebook, Instagram and TikTok.

Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20260409646752/da/

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release

Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release

A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release

New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye